Farber’s disease is a rare inherited condition involving the breakdown and use of fats in the body. In affected individuals, lipids accumulate abnormally in cells and tissues throughout the body, particularly around the joints. The deficiency of an enzyme is called ceramidase resulting in the harmful accumulation of certain chemicals in the body, which causes damage and inflammation. Three classic signs occur in Farber lipogranulomatosis: a hoarse voice or a weak cry, small lumps of fat under the skin and in other tissues (lipogranulomas), and swollen and painful joints. Affected individuals may also have difficulty breathing, an enlarged liver and spleen (hepatosplenomegaly), and developmental delay.
This report contains market size and forecasts of Farber's Disease in Global, including the following market information:
Global Farber's Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Farber's Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Farber's Disease include F. Hoffmann-La Roche Ltd, Pfizer Inc, GlaxoSmithKline plc, Cardinal Health, Endo Pharmaceuticals Inc, Impax Laboratories, Teva Pharmaceutical Industries Ltd, Mylan N.V and Kowa Pharmaceuticals America, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Farber's Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Farber's Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Farber's Disease Market Segment Percentages, by Type, 2021 (%)
Medication
Surgery
Global Farber's Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Farber's Disease Market Segment Percentages, by Application, 2021 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Farber's Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Farber's Disease Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Farber's Disease revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Farber's Disease revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd
Pfizer Inc
GlaxoSmithKline plc
Cardinal Health
Endo Pharmaceuticals Inc
Impax Laboratories
Teva Pharmaceutical Industries Ltd
Mylan N.V
Kowa Pharmaceuticals America
Sun Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
WOCKHARDT
Novartis AG
Merck & Co
Takeda Pharmaceutical Company Limited
AstraZeneca
Boehringer Ingelheim International GmbH
Enzyvant